CTGF levels were significantly lower in all treatment groups than in the IH group, but the combined treatment showed the greatest reduction in the IH-increased expression of CTGF (Figures 4(c) and 4(f)). This evidence concerns the gene CCN2 and isolated hemihyperplasia.